What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Gene
His primary scientific interests are in Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Genetics.
The concepts of his Endocrinology study are interwoven with issues in Odds ratio, Gastroenterology and Allele frequency.
His Diabetes mellitus research includes elements of Cohort study and Risk factor.
His Type 2 diabetes research integrates issues from Carbohydrate metabolism, Glucokinase, Pediatrics and Mass screening.
His research on Genetics frequently connects to adjacent areas such as Case-control study.
His study in Genome-wide association study is interdisciplinary in nature, drawing from both CDKAL1 and SLC30A8.
His most cited work include:
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes (2200 citations)
- European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. (2004 citations)
- Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes (1618 citations)
What are the main themes of his work throughout his whole career to date?
Knut Borch-Johnsen mostly deals with Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Obesity.
His study involves Insulin, Risk factor, Glucose tolerance test, Body mass index and Odds ratio, a branch of Internal medicine.
Knut Borch-Johnsen focuses mostly in the field of Risk factor, narrowing it down to topics relating to Microalbuminuria and, in certain cases, Albuminuria and Cardiology.
His studies in Endocrinology integrate themes in fields like Genotype, Polymorphism, Allele and Allele frequency.
His Diabetes mellitus study integrates concerns from other disciplines, such as Surgery, Epidemiology and Disease.
In his study, which falls under the umbrella issue of Type 2 diabetes, Case-control study is strongly linked to Genetics.
He most often published in these fields:
- Internal medicine (98.19%)
- Endocrinology (86.43%)
- Diabetes mellitus (69.68%)
What were the highlights of his more recent work (between 2009-2019)?
- Diabetes mellitus (69.68%)
- Internal medicine (98.19%)
- Type 2 diabetes (72.17%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Diabetes mellitus, Internal medicine, Type 2 diabetes, Endocrinology and Impaired glucose tolerance.
His work on Impaired fasting glucose as part of general Diabetes mellitus study is frequently connected to Risk assessment, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His work in Internal medicine tackles topics such as Retinopathy which are related to areas like Diabetic retinopathy.
His Type 2 diabetes study incorporates themes from Framingham Risk Score, Surgery, Type 2 Diabetes Mellitus and Mass screening.
The study incorporates disciplines such as Genetics and Single-nucleotide polymorphism in addition to Endocrinology.
His Genetics research is multidisciplinary, incorporating elements of Childhood obesity and Overweight.
Between 2009 and 2019, his most popular works were:
- Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. (249 citations)
- Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. (249 citations)
- A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes (244 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Gene
The scientist’s investigation covers issues in Internal medicine, Diabetes mellitus, Type 2 diabetes, Endocrinology and Impaired glucose tolerance.
His work deals with themes such as Retinopathy, Linear regression and Immunology, which intersect with Internal medicine.
His Diabetes mellitus research includes themes of Body mass index, Prospective cohort study, Family medicine and Risk factor.
His study on Diabetes risk is often connected to Cost-effectiveness analysis as part of broader study in Type 2 diabetes.
His research integrates issues of Genetics and Type 2 Diabetes Mellitus in his study of Diabetes risk.
His Impaired glucose tolerance research incorporates themes from Continuous glucose monitoring, Human physiology, Fasting glucose, Non diabetic and Reference values.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
